BGNE
Price
$176.09
Change
-$2.97 (-1.66%)
Updated
Dec 18, 04:08 PM (EDT)
98 days until earnings call
LEGN
Price
$34.46
Change
-$0.22 (-0.63%)
Updated
Dec 18, 04:21 PM (EDT)
85 days until earnings call
Ad is loading...

BGNE vs LEGN

Header iconBGNE vs LEGN Comparison
Open Charts BGNE vs LEGNBanner chart's image
BeiGene
Price$176.09
Change-$2.97 (-1.66%)
Volume$302
CapitalizationN/A
Legend Biotech
Price$34.46
Change-$0.22 (-0.63%)
Volume$300
CapitalizationN/A
BGNE vs LEGN Comparison Chart
Loading...
BGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LEGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BGNE vs. LEGN commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGNE is a Hold and LEGN is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (BGNE: $179.06 vs. LEGN: $34.68)
Brand notoriety: BGNE and LEGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BGNE: 79% vs. LEGN: 128%
Market capitalization -- BGNE: $19.97B vs. LEGN: $6.36B
BGNE [@Biotechnology] is valued at $19.97B. LEGN’s [@Biotechnology] market capitalization is $6.36B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BGNE’s FA Score shows that 0 FA rating(s) are green whileLEGN’s FA Score has 0 green FA rating(s).

  • BGNE’s FA Score: 0 green, 5 red.
  • LEGN’s FA Score: 0 green, 5 red.
According to our system of comparison, BGNE is a better buy in the long-term than LEGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BGNE’s TA Score shows that 3 TA indicator(s) are bullish while LEGN’s TA Score has 4 bullish TA indicator(s).

  • BGNE’s TA Score: 3 bullish, 6 bearish.
  • LEGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, LEGN is a better buy in the short-term than BGNE.

Price Growth

BGNE (@Biotechnology) experienced а -4.50% price change this week, while LEGN (@Biotechnology) price change was -8.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.45%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

BGNE is expected to report earnings on Mar 26, 2025.

LEGN is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BGNE($20B) has a higher market cap than LEGN($6.36B). BGNE YTD gains are higher at: -0.721 vs. LEGN (-42.363). LEGN has higher annual earnings (EBITDA): -301.26M vs. BGNE (-727.23M). BGNE has more cash in the bank: 2.7B vs. LEGN (1.21B). LEGN has less debt than BGNE: LEGN (347M) vs BGNE (1.1B). BGNE has higher revenues than LEGN: BGNE (3.32B) vs LEGN (520M).
BGNELEGNBGNE / LEGN
Capitalization20B6.36B314%
EBITDA-727.23M-301.26M241%
Gain YTD-0.721-42.3632%
P/E RatioN/AN/A-
Revenue3.32B520M638%
Total Cash2.7B1.21B223%
Total Debt1.1B347M317%
FUNDAMENTALS RATINGS
BGNE: Fundamental Ratings
BGNE
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BGNELEGN
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
75%
Bullish Trend 16 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
79%
View a ticker or compare two or three
Ad is loading...
BGNE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LEGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSY0.75N/A
-0.13%
SunLink Health Systems
ALLE136.64-0.40
-0.29%
Allegion Public Limited
MOV20.16-0.06
-0.30%
Movado Group
GSAT1.90-0.05
-2.56%
Globalstar
ENTA6.13-0.18
-2.85%
Enanta Pharmaceuticals

BGNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BGNE has been loosely correlated with ZLAB. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if BGNE jumps, then ZLAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGNE
1D Price
Change %
BGNE100%
+1.55%
ZLAB - BGNE
43%
Loosely correlated
+3.02%
MDGL - BGNE
42%
Loosely correlated
-1.58%
DNLI - BGNE
41%
Loosely correlated
-0.30%
WXXWY - BGNE
37%
Loosely correlated
-0.99%
AXON - BGNE
37%
Loosely correlated
-2.09%
More

LEGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LEGN has been loosely correlated with BGNE. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LEGN jumps, then BGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEGN
1D Price
Change %
LEGN100%
+5.06%
BGNE - LEGN
38%
Loosely correlated
+1.55%
AXON - LEGN
37%
Loosely correlated
-2.09%
ALNY - LEGN
33%
Loosely correlated
+1.06%
GOSS - LEGN
33%
Poorly correlated
+1.71%
SRPT - LEGN
32%
Poorly correlated
-0.81%
More